Annovis Bio (FRA:07X) FCF Margin %: 0.00% (As of Mar. 2026)


FRA:07X Annovis Bio Inc FRA:07X
32 GF Score
Price €1.48
! 1 Warning Sign
View Full Analysis

What is Annovis Bio FCF Margin %?

Annovis Bio FRA:07X -2.64% 32 FCF Margin % is 0.00% as of Mar. 2026. GuruFocus rates FRA:07X with a GF Score™ of 32/100. The stock has 1 warning sign investors should review. Among 959 Biotechnology companies, Annovis Bio ranks worse than 104275.18% on this metric.

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Annovis Bio's Free Cash Flow for the three months ended in Mar. 2026 was €-7.80 Mil. Annovis Bio's Revenue for the three months ended in Mar. 2026 was €0.00 Mil. Therefore, Annovis Bio's FCF Margin % for the quarter that ended in Mar. 2026 was 0.00%.

As of today, Annovis Bio's current FCF Yield % is -37.80%.

The historical rank and industry rank for Annovis Bio's FCF Margin % or its related term are showing as below:


FRA:07X's FCF Margin % is not ranked *
in the Biotechnology industry.
Industry Median: -84.65
* Ranked among companies with meaningful FCF Margin % only.

Annovis Bio FCF Margin % Related Terms

Annovis Bio FCF Margin % Historical Data

* Premium members only.

The historical data trend for Annovis Bio's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Annovis Bio FCF Margin % Chart

Annovis Bio Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
FCF Margin %
Get a 7-Day Free Trial Premium Member Only 0.00 0.00 0.00 0.00 0.00

Annovis Bio Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
FCF Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

FRA:07X vs CSBR, HYFT, GANX: FCF Margin % Comparison

For the Biotechnology subindustry, Annovis Bio's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Annovis Bio FCF Margin % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Annovis Bio's FCF Margin % distribution charts can be found below:

* The bar in red indicates where Annovis Bio's FCF Margin % falls into.


FRA:07X
32GF Score
Annovis Bio Inc FRA:07X
FCF Margin % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Annovis Bio FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

Annovis Bio's FCF Margin for the fiscal year that ended in Dec. 2025 is calculated as

FCF Margin=Free Cash Flow (A: Dec. 2025 )/Revenue (A: Dec. 2025 )
=-21.879/0
= %

Annovis Bio's FCF Margin for the quarter that ended in Mar. 2026 is calculated as

FCF Margin=Free Cash Flow (Q: Mar. 2026 )/Revenue (Q: Mar. 2026 )
=-7.795/0
= %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about FCF Margin % →
What does a FCF Margin % of 0.00% mean?
Annovis Bio (FRA:07X) has a FCF Margin % of 0.00% as of Mar. 2026. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Annovis Bio and its competitors. According to the industry distribution chart, Annovis Bio ranks #999999 out of 959 companies in the Biotechnology industry.
Is Annovis Bio's FCF Margin % too high?
Annovis Bio's current FCF Margin % is 0.00%. Based on the distribution chart, Annovis Bio ranks #999999 out of 959 companies in the Biotechnology industry, which is in the bottom quartile relative to peers. Overall, Annovis Bio has a GF Score™ of 32/100, reflecting its overall financial health beyond just this single metric.
How does Annovis Bio's FCF Margin % compare to CSBR and HYFT?
According to the Biotechnology industry distribution chart, Annovis Bio ranks #999999 out of 959 companies for FCF Margin %. This places Annovis Bio in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Margin % for a Biotechnology company?
A good FCF Margin % depends on the Biotechnology industry context. However, FCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Margin % mean?
A high FCF Margin % can signal that a stock is expensive relative to its fundamentals. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Annovis Bio and its competitors. Annovis Bio's current FCF Margin % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Annovis Bio stock overvalued right now?
Annovis Bio (FRA:07X) has a current FCF Margin % of 0.00%. The current FCF Margin % is 0.00%. Annovis Bio's overall GF Score™ is 32/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Margin % calculated?
FCF Margin % is calculated from a company's financial statements. For Annovis Bio (FRA:07X), the current FCF Margin % is 0.00% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Annovis Bio Business Description

Other Exchanges ANVS:USA
Address 101 Lindenwood Drive, Suite 225, Malvern, PA, USA, 19355
Annovis Bio Inc, a clinical stage drug platform company, develops drugs to treat neurodegeneration in the United States. The company's flagship candidate, buntanetap, is in clinical trials for the treatment of Alzheimer's disease, Parkinson's disease, and Lewy body dementia. It also develops ANVS405, which is in phase 2 and 3 clinical trials for the treatment of traumatic brain injury and/or stroke; and ANVS301, which finished phase 1 clinical trial developed to increase cognitive capability in later stages of alzheimer's disease and dementia.
32GF Score

Get the complete analysis for FRA:07X

FCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€1.48
Price